T790M inhibitor as first line therapy: Promises and pitfalls

Date 13 April 2016
Event European Lung Cancer Conference 2016 (ELCC) 2016
Session Targeting T790M
Topics Cytotoxic agents
Translational Research
Non-small-cell lung cancer
Basic Principles in the Management and Treatment (of cancer)
Therapy
Biological therapy
Presenter David Planchard
Authors D. Planchard
  • Gustave Roussy Institut, Villejuif/FR